Tufan Bilgin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tufan Bilgin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Hakan Ozan
Uludag University
4 shared publicationsSema Özuysal
Uludag University
3 shared publicationsA. Karabay
From the Departments of Obstetrics and Gynecology, and
1 shared publicationE. Dolar
Gastroenterology, Uludağ University, Faculty of Medicine, Bursa, Turkey
1 shared publication- Kemal Ozerkan
Istanbul University, School of Physical Education and Sport, Physical Education Teaching Department
1 shared publication Lütfi Özkan
Department of Radiation Oncology, Faculty of Medicine, Uludağ University, Bursa, Turkey
1 shared publication
Latest Publications
- 5 June 2006
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 32 (3) , 305-308
Effects of hormone replacement therapy regimens on mammographic breast density: The role of progestins
To evaluate the effects of different regimens of hormone replacement therapy (HRT) on mammographic breast density. Mammograms of 113 healthy postmenopausal women who were on different HRT regimens were evaluated retrospectively. All women had a baseline mammography and at least one mammogram after at least 12 months of HRT. Four parenchymal patterns were considered mammographically. Quantification of density changes that occurred on follow-up mammograms was done qualitatively and with reference to densities on baseline mammograms. Sixty women were treated with a continuous estrogen-progestin combination; 16 with a cyclic estrogen-progestin combination and 37 were with estrogen only. Twenty-six women had increased mammographic density after HRT. Mammographic density increase was detected in 23 women (38.3%) of the continuous estrogen-progestin combination group, two women (12.5%) of the cyclic estrogen-progestin combination group and one woman (2.7%) of the estrogen-only group. Mammographic density increase was more common among women in the continuous estrogen-progestin combination group than the other groups and this difference was found to be statistically significant (P < 0.001). Breast density increase was observed in 18 of 30 women (60%) with higher doses of progestin compared to 5 of 30 women (16.7%) with lower dose (P < 0.05). Postmenopausal HRT may increase mammographic breast density. Breast density appears to be mostly affected by higher doses and continuous administration of progestin.
- 5 June 2006
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 32 (3) , 305-308
Effects of hormone replacement therapy regimens on mammographic breast density: The role of progestins
To evaluate the effects of different regimens of hormone replacement therapy (HRT) on mammographic breast density. Mammograms of 113 healthy postmenopausal women who were on different HRT regimens were evaluated retrospectively. All women had a baseline mammography and at least one mammogram after at least 12 months of HRT. Four parenchymal patterns were considered mammographically. Quantification of density changes that occurred on follow-up mammograms was done qualitatively and with reference to densities on baseline mammograms. Sixty women were treated with a continuous estrogen-progestin combination; 16 with a cyclic estrogen-progestin combination and 37 were with estrogen only. Twenty-six women had increased mammographic density after HRT. Mammographic density increase was detected in 23 women (38.3%) of the continuous estrogen-progestin combination group, two women (12.5%) of the cyclic estrogen-progestin combination group and one woman (2.7%) of the estrogen-only group. Mammographic density increase was more common among women in the continuous estrogen-progestin combination group than the other groups and this difference was found to be statistically significant (P < 0.001). Breast density increase was observed in 18 of 30 women (60%) with higher doses of progestin compared to 5 of 30 women (16.7%) with lower dose (P < 0.05). Postmenopausal HRT may increase mammographic breast density. Breast density appears to be mostly affected by higher doses and continuous administration of progestin.
- 7 July 2004
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 272 (1) , 23-25
A comparison of three histological grading systems in endometrial cancer
- 7 July 2004
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 272 (1) , 23-25
A comparison of three histological grading systems in endometrial cancer
- 7 May 2004
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 30 (3) , 205-209
Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia
Aim: To investigate the possibility of coexisting endometrial cancer (EC) in patients with atypical endometrial hyperplasia (AEH).Methods: Forty‐six consecutive women who underwent hysterectomy for AEH were analyzed.Results: Final histopathological evaluation of hysterectomy specimens revealed EC in 11 patients (23.9%). Preoperative diagnosis of AEH was established by pipelle biopsy in eight patients and curettage was performed in the remaining patients. Of the patients with pipelle biopsy, two had a diagnosis of EC (25%), whereas nine women who underwent curettage, were further diagnosed as having EC (23.7%) (P > 0.05). Four (13.3%) of 30 women who had frozen sections at hysterectomy, were diagnosed with EC. Diagnosis of EC was missed in two patients (50%) at frozen section. In contrast, seven of 16 women (43.7%) who did not have frozen section, had EC.Conclusion: A relatively high incidence of EC is seen in patients with a diagnosis of AEH. Diagnostic results of pipelle biopsy and curettage were comparable. Frozen sections of hysterectomy specimens does not guarantee to exclude the possibility of EC, especially in patients with no myometrial invasion.
- 7 May 2004
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 30 (3) , 205-209
Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia
Aim: To investigate the possibility of coexisting endometrial cancer (EC) in patients with atypical endometrial hyperplasia (AEH).Methods: Forty‐six consecutive women who underwent hysterectomy for AEH were analyzed.Results: Final histopathological evaluation of hysterectomy specimens revealed EC in 11 patients (23.9%). Preoperative diagnosis of AEH was established by pipelle biopsy in eight patients and curettage was performed in the remaining patients. Of the patients with pipelle biopsy, two had a diagnosis of EC (25%), whereas nine women who underwent curettage, were further diagnosed as having EC (23.7%) (P > 0.05). Four (13.3%) of 30 women who had frozen sections at hysterectomy, were diagnosed with EC. Diagnosis of EC was missed in two patients (50%) at frozen section. In contrast, seven of 16 women (43.7%) who did not have frozen section, had EC.Conclusion: A relatively high incidence of EC is seen in patients with a diagnosis of AEH. Diagnostic results of pipelle biopsy and curettage were comparable. Frozen sections of hysterectomy specimens does not guarantee to exclude the possibility of EC, especially in patients with no myometrial invasion.
- 2 March 2004
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 271 (4) , 329-331
Splenectomy in cytoreductive surgery for advanced ovarian cancer
To evaluate the series of advanced ovarian cancer patients who underwent splenectomy as part of their surgery, a retrospective file review of 258 ovarian cancer cases were examined.
- 2 March 2004
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 271 (4) , 329-331
Splenectomy in cytoreductive surgery for advanced ovarian cancer
To evaluate the series of advanced ovarian cancer patients who underwent splenectomy as part of their surgery, a retrospective file review of 258 ovarian cancer cases were examined.
- 13 November 2002
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 269 (2) , 159-160
Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP)
A 26-year-old woman who had been treated for nonmetastatic gestational trophoblastic tumor with three courses of methotrexate with folinic acid rescue and had been lost to follow up for 4 years was referred with the fractional curettage diagnosis of choriocarcinoma that had been performed for abnormal vaginal bleeding. Her serum beta human chorionic gonadotropin (βhCG) was 706,000 mIU/mL and there were multiple pulmonary metastatic foci. The uterus was 12 weeks pregnant-size and a 6×6-cm tumor mass was seen within the anterior uterine wall at ultrasonography. Following total abdominal hysterectomy etoposide, methotrexate, actinomycin-D, vincristine and cyclophosphamide (EMA/CO) regimen was given. Whole brain radiation of 30 Gy in 3 weeks for brain metastasis, discovered in magnetic resonance imaging was given after the first course. Since serum βhCG levels plateaued after three courses of chemotherapy and multiple pulmonary metastases persisted, treatment was shifted to etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP) regimen. She was in remission after three courses of chemotherapy.
- 13 November 2002
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 269 (2) , 159-160
Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP)
A 26-year-old woman who had been treated for nonmetastatic gestational trophoblastic tumor with three courses of methotrexate with folinic acid rescue and had been lost to follow up for 4 years was referred with the fractional curettage diagnosis of choriocarcinoma that had been performed for abnormal vaginal bleeding. Her serum beta human chorionic gonadotropin (βhCG) was 706,000 mIU/mL and there were multiple pulmonary metastatic foci. The uterus was 12 weeks pregnant-size and a 6×6-cm tumor mass was seen within the anterior uterine wall at ultrasonography. Following total abdominal hysterectomy etoposide, methotrexate, actinomycin-D, vincristine and cyclophosphamide (EMA/CO) regimen was given. Whole brain radiation of 30 Gy in 3 weeks for brain metastasis, discovered in magnetic resonance imaging was given after the first course. Since serum βhCG levels plateaued after three courses of chemotherapy and multiple pulmonary metastases persisted, treatment was shifted to etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP) regimen. She was in remission after three courses of chemotherapy.
- 29 July 2001
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 11 (4) , 290-294
Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: A series of 10 cases
- 29 July 2001
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 11 (4) , 290-294
Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: A series of 10 cases
- 1 January 2000
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 20 (3) , 323
Late ovarian metastases of a cutaneous malignant melanoma
(2000). Late ovarian metastases of a cutaneous malignant melanoma. Journal of Obstetrics and Gynaecology: Vol. 20, No. 3, pp. 323-323.
- 1 January 2000
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 20 (3) , 323
Late ovarian metastases of a cutaneous malignant melanoma
(2000). Late ovarian metastases of a cutaneous malignant melanoma. Journal of Obstetrics and Gynaecology: Vol. 20, No. 3, pp. 323-323.
- 1 January 1999
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 19 (6) , 671-672
Primary malignant lymphoma of the uterine cervix: difficulties in diagnosis
- 1 January 1999
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 19 (6) , 671-672
Primary malignant lymphoma of the uterine cervix: difficulties in diagnosis